Akèy › Twoub depresif rezistan a tretman › Maryland
Etid klinik pou Twoub depresif rezistan a tretman nan Maryland
6 etid pou Twoub depresif rezistan a tretman ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Long-term Observation of Participants With Mood Disorders
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Oct 1, 2026 · NCT04877977Natural History of Depression, Bipolar Disorder and Suicide Risk
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Oct 1, 2026 · NCT06462196Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 14, 2026 · NCT06511908A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Sheppard Pratt Health System, Inc., Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Sheppard Pratt, Baltimore
- Sunstone Medical, PC, Rockville
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830ALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Site 7151, Annapolis
- Site 7054, Pikesville
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Apr 28, 2026 · NCT07553637Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.